Heart Test Laboratories Inc. - HSCS Net earnings per share for the last four quarters

Public company logo of Heart Test Laboratories, Inc. (HSCS)

The industry trend toward automating cardiac pathology screening relies on Heart Test Laboratories (HSCS) AI algorithms. This YoY ttm earnings per share chart reflects current market dynamics, where the indicator value stands at 61.80. A fabless model utilizing US plants guarantees supply stability, while an excellent base of calibration laboratories ensures readiness for the mass production of systems.

HSCS heartsciences.com: Net earnings per share (EPS TTM) in the range 02/11/2024 - 11/12/2026

Heart Test Laboratories Inc. - analytical breakdowns and key metrics (HSCS)

- market price and analyst price targets:
Initial company analysis:heartsciences.com HSCS
Core merchandise of Heart Test Laboratories Inc.

This indicator reflects the dynamics of net earnings per share, adjusted for seasonality over the last four quarters. By analyzing the 12-month YoY EPS growth rate, an investor assesses the actual speed of business scaling. The calculation is based on a comparison of the current total EPS TTM against the same period last year. For Heart Test Laboratories (HSCS), this metric confirms the effectiveness of implementing AI diagnostics. Stable growth here offsets the risks of slow equipment commercialization.

Direct competitors

Net earnings per share for the last four quarters agilent.com A|DGX: Net earnings per share (EPS TTM)|ILMN - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Cologuard|Revvity Corp (RVTY) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) BIO|NNNN (anbio.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) SHC (Sotera Health)|Quidel Corporation (QDEL) - Net earnings per one share for the last twelve months|OPKO Corp - Net earnings per share (EPS TTM)|CDNA - Net earnings per share (EPS TTM)|Maravai LifeSciences (MRVI) - Earnings per share for the last twelve months|fulgentgenetics.com - Earnings per share for the trailing year|Net earnings per share for the last 12 months LAB|CTKB (Cytek Biosciences Inc) - Earnings per share for the last four quarters|Net earnings per share for the last 12 months OSUR (OraSure Technologies Inc)|XGN (exagen.com) - Earnings per share for the trailing year|MDxHealth SA - Net earnings per share for the last 12 months|Earnings per share for the last four quarters LUCD (luciddx.com)|Prenetics Global Ltd - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Insight Molecular Diagnostics|trinitybiotech.com (TRIB) - Earnings per share for the last twelve months|PRPH - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months AIMD|CODX (codiagnostics.com) - Earnings per share for the last four quarters|Net earnings per share for the last 12 months BMRA (Biomerica)|CDIO (cardiodiagnosticsinc.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Onconetix Corp ONCO|Virax Biolabs Corp - Earnings per share for the last twelve months|Bluejay Diagnostics - Net earnings per share (EPS TTM)|AWH - Net earnings per share (EPS TTM)|AXDX: Net earnings per share (EPS TTM)|CNTG (centogene.com) - Earnings per share for the last twelve months|Earnings per share for the last twelve months Enzo Biochem Inc.|Net earnings per one share for the last twelve months Fresh2 FRES|Earnings per share for the last twelve months Genetic Technologies (GENE)|ME (23andme.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) PMD (Psychemedics Corporation)